Palatin Technologies, Inc. (PTN)
USD 0.75
(-9.64%)
USD 0.75
(-9.64%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 | -2.02 USD | 20.16% |
| 2023 | -2.53 USD | 32.53% |
| 2022 | -3.75 USD | -5.63% |
| 2021 | -3.55 USD | -49.16% |
| 2020 | -2.38 USD | -155.22% |
| 2019 | 4.31 USD | 38.14% |
| 2018 | 3.12 USD | 272.38% |
| 2017 | -1.81 USD | 78.09% |
| 2016 | -8.26 USD | -126.3% |
| 2015 | -3.65 USD | -11.96% |
| 2014 | -3.26 USD | 38.95% |
| 2013 | -5.34 USD | 56.8% |
| 2012 | -12.36 USD | 22.51% |
| 2011 | -15.95 USD | -251.32% |
| 2010 | -4.54 USD | 67.34% |
| 2009 | -13.90 USD | 67.06% |
| 2008 | -42.20 USD | 53.65% |
| 2007 | -91.04 USD | 24.1% |
| 2006 | -119.95 USD | -80.0% |
| 2005 | -66.64 USD | 51.7% |
| 2004 | -137.97 USD | 23.89% |
| 2003 | -181.27 USD | 36.22% |
| 2002 | -284.23 USD | -8.67% |
| 2001 | -261.55 USD | 4.87% |
| 2000 | -274.94 USD | 45.6% |
| 1999 | -505.37 USD | 34.45% |
| 1998 | -770.91 USD | -70.12% |
| 1997 | -453.15 USD | 68.38% |
| 1996 | -1433.33 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.48 USD | 47.25% |
| 2024 Q4 | -0.49 USD | -5.66% |
| 2024 Q3 | -0.53 USD | 5.36% |
| 2024 Q2 | -0.56 USD | -16.67% |
| 2023 FY | - USD | 32.53% |
| 2023 Q3 | -0.61 USD | -369.23% |
| 2023 Q2 | -0.13 USD | 84.88% |
| 2023 Q1 | -0.86 USD | 35.82% |
| 2023 Q4 | -0.91 USD | -49.18% |
| 2022 FY | - USD | -5.63% |
| 2022 Q1 | -0.75 USD | 48.98% |
| 2022 Q2 | -0.91 USD | -21.33% |
| 2022 Q3 | -0.78 USD | 14.29% |
| 2022 Q4 | -1.34 USD | -71.79% |
| 2021 Q1 | -0.42 USD | 46.15% |
| 2021 FY | - USD | -49.16% |
| 2021 Q2 | -1.06 USD | -152.38% |
| 2021 Q3 | -0.60 USD | 43.4% |
| 2021 Q4 | -1.47 USD | -145.0% |
| 2020 Q3 | -0.57 USD | -1.79% |
| 2020 Q1 | -0.48 USD | -108.57% |
| 2020 Q2 | -0.56 USD | -16.67% |
| 2020 Q4 | -0.78 USD | -36.84% |
| 2020 FY | - USD | -155.22% |
| 2019 Q2 | -0.61 USD | 11.59% |
| 2019 Q1 | -0.69 USD | -147.92% |
| 2019 Q3 | -0.69 USD | -13.11% |
| 2019 Q4 | 5.60 USD | 911.59% |
| 2019 FY | - USD | 38.14% |
| 2018 Q2 | 0.50 USD | -60.0% |
| 2018 Q1 | 1.25 USD | -26.04% |
| 2018 FY | - USD | 272.38% |
| 2018 Q3 | -0.09 USD | -118.9% |
| 2018 Q4 | 1.44 USD | 1623.81% |
| 2017 Q3 | -0.45 USD | 68.09% |
| 2017 Q4 | 1.69 USD | 475.56% |
| 2017 FY | - USD | 78.09% |
| 2017 Q2 | -1.41 USD | 28.43% |
| 2017 Q1 | -1.97 USD | 1.99% |
| 2016 Q3 | -2.03 USD | 4.25% |
| 2016 Q4 | -2.01 USD | 0.99% |
| 2016 FY | - USD | -126.3% |
| 2016 Q2 | -2.12 USD | -6.53% |
| 2016 Q1 | -1.99 USD | -3.11% |
| 2015 Q4 | -1.93 USD | -12.87% |
| 2015 Q2 | 0.75 USD | 200.0% |
| 2015 FY | - USD | -11.96% |
| 2015 Q3 | -1.71 USD | -328.0% |
| 2015 Q1 | 0.25 USD | 124.75% |
| 2014 Q3 | -0.35 USD | 58.82% |
| 2014 Q2 | -0.85 USD | 19.05% |
| 2014 Q1 | -1.05 USD | 5.41% |
| 2014 FY | - USD | 38.95% |
| 2014 Q4 | -1.01 USD | -188.57% |
| 2013 Q3 | -0.94 USD | -141.03% |
| 2013 Q4 | -1.11 USD | -18.09% |
| 2013 FY | - USD | 56.8% |
| 2013 Q1 | -3.65 USD | -99.45% |
| 2013 Q2 | -0.39 USD | 89.32% |
| 2012 FY | - USD | 22.51% |
| 2012 Q4 | -1.83 USD | 57.54% |
| 2012 Q3 | -4.31 USD | -129.26% |
| 2012 Q2 | -1.88 USD | 21.67% |
| 2012 Q1 | -2.40 USD | -1.27% |
| 2011 FY | - USD | -251.32% |
| 2011 Q4 | -2.37 USD | 43.17% |
| 2011 Q3 | -4.17 USD | -79.74% |
| 2011 Q2 | -2.32 USD | 76.33% |
| 2011 Q1 | -9.80 USD | -8.53% |
| 2010 Q4 | -9.03 USD | -78.46% |
| 2010 Q2 | 10.50 USD | 10600.0% |
| 2010 Q1 | -0.10 USD | 81.82% |
| 2010 FY | - USD | 67.34% |
| 2010 Q3 | -5.06 USD | -148.19% |
| 2009 FY | - USD | 67.06% |
| 2009 Q2 | -1.20 USD | 90.42% |
| 2009 Q3 | 0.36 USD | 130.0% |
| 2009 Q4 | -0.55 USD | -252.78% |
| 2009 Q1 | -12.52 USD | 18.49% |
| 2008 FY | - USD | 53.65% |
| 2008 Q1 | -0.72 USD | 96.0% |
| 2008 Q2 | -11.10 USD | -1441.67% |
| 2008 Q3 | -15.00 USD | -35.14% |
| 2008 Q4 | -15.36 USD | -2.4% |
| 2007 Q1 | -29.76 USD | -4.13% |
| 2007 FY | - USD | 24.1% |
| 2007 Q3 | -21.53 USD | 5.69% |
| 2007 Q2 | -22.83 USD | 23.29% |
| 2007 Q4 | -17.99 USD | 16.44% |
| 2006 FY | - USD | -80.0% |
| 2006 Q2 | -31.61 USD | -14.16% |
| 2006 Q4 | -28.58 USD | 10.77% |
| 2006 Q3 | -32.03 USD | -1.33% |
| 2006 Q1 | -27.69 USD | -17.58% |
| 2005 Q1 | -14.24 USD | 57.04% |
| 2005 Q2 | -10.59 USD | 25.63% |
| 2005 Q3 | -18.23 USD | -72.14% |
| 2005 FY | - USD | 51.7% |
| 2005 Q4 | -23.55 USD | -29.18% |
| 2004 FY | - USD | 23.89% |
| 2004 Q2 | -25.77 USD | 33.79% |
| 2004 Q3 | -39.78 USD | -54.37% |
| 2004 Q4 | -33.15 USD | 16.67% |
| 2004 Q1 | -38.92 USD | -3.98% |
| 2003 Q2 | -43.74 USD | 21.05% |
| 2003 Q4 | -37.43 USD | 20.09% |
| 2003 Q3 | -46.84 USD | -7.09% |
| 2003 Q1 | -55.40 USD | 18.49% |
| 2003 FY | - USD | 36.22% |
| 2002 Q3 | -66.11 USD | 8.78% |
| 2002 FY | - USD | -8.67% |
| 2002 Q1 | -80.41 USD | 8.22% |
| 2002 Q2 | -72.47 USD | 9.87% |
| 2002 Q4 | -67.97 USD | -2.81% |
| 2001 FY | - USD | 4.87% |
| 2001 Q4 | -87.61 USD | -45.6% |
| 2001 Q3 | -60.17 USD | -36.69% |
| 2001 Q2 | -44.02 USD | 35.97% |
| 2001 Q1 | -68.75 USD | 0.2% |
| 2000 Q4 | -68.89 USD | -13.72% |
| 2000 Q2 | -96.65 USD | -93.3% |
| 2000 Q3 | -60.58 USD | 37.32% |
| 2000 Q1 | -50.00 USD | 64.1% |
| 2000 FY | - USD | 45.6% |
| 1999 Q4 | -139.29 USD | -5.12% |
| 1999 Q1 | -165.00 USD | 9.09% |
| 1999 Q2 | -115.00 USD | 30.3% |
| 1999 FY | - USD | 34.45% |
| 1999 Q3 | -132.50 USD | -15.22% |
| 1998 Q1 | -162.50 USD | -14.04% |
| 1998 FY | - USD | -70.12% |
| 1998 Q4 | -181.50 USD | 5.71% |
| 1998 Q2 | -180.00 USD | -10.77% |
| 1998 Q3 | -192.49 USD | -6.94% |
| 1997 Q4 | -142.50 USD | -41.28% |
| 1997 Q1 | -90.52 USD | 0.0% |
| 1997 FY | - USD | 68.38% |
| 1997 Q3 | -100.86 USD | -16.99% |
| 1997 Q2 | -86.21 USD | 4.76% |
| 1996 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AIM ImmunoTech Inc. | -0.60 USD | -236.667% |
| Ampio Pharmaceuticals, Inc. | -10.67 USD | 81.068% |
| Armata Pharmaceuticals, Inc. | -1.91 USD | -5.759% |
| Actinium Pharmaceuticals, Inc. | -1.83 USD | -10.383% |
| Azitra, Inc. | -54.76 USD | 96.311% |
| Can-Fite BioPharma Ltd. | -1.79 USD | -12.849% |
| Chromocell Therapeutics Corporation | -1.28 USD | -57.813% |
| Calidi Biotherapeutics, Inc. | -1.73 USD | -16.763% |
| CEL-SCI Corporation | -0.73 USD | -176.712% |
| iBio, Inc. | -6.50 USD | 68.923% |
| Lineage Cell Therapeutics, Inc. | -0.12 USD | -1583.333% |
| MAIA Biotechnology, Inc. | -1.49 USD | -35.57% |
| Matinas BioPharma Holdings, Inc. | -5.28 USD | 61.742% |
| Navidea Biopharmaceuticals, Inc. | -0.59 USD | -242.373% |
| NovaBay Pharmaceuticals, Inc. | -138.65 USD | 98.543% |
| NanoViricides, Inc. | -0.70 USD | -188.571% |
| Oragenics, Inc. | -9.18 USD | 77.996% |
| BiomX Inc. | -5.10 USD | 60.392% |
| BiomX Inc. | -5.10 USD | 60.392% |
| Protalix BioTherapeutics, Inc. | 0.12 USD | 1783.333% |
| Scorpius Holdings, Inc. | -347.20 USD | 99.418% |